Literature DB >> 20923998

Azathioprine-induced carcinogenesis in mice according to Msh2 genotype.

Alexandra Chalastanis1, Virginie Penard-Lacronique, Magali Svrcek, Valérie Defaweux, Nadine Antoine, Olivier Buhard, Sylvie Dumont, Bettina Fabiani, Isabelle Renault, Emmanuel Tubacher, Jean-François Fléjou, Hein Te Riele, Alex Duval, Martine Muleris.   

Abstract

BACKGROUND: The thiopurine prodrug azathioprine is used extensively in cancer therapy. Exposure to this drug results in the selection of DNA mismatch repair-deficient cell clones in vitro. It has also been suggested that thiopurine drugs might constitute a risk factor for the emergence of human neoplasms displaying microsatellite instability (MSI) because of deficient DNA mismatch repair.
METHODS: Azathioprine was administered via drinking water (6-20 mg/kg body weight per day) to mice that were null (Msh2⁻(/)⁻; n = 27), heterozygous (Msh2(+/)⁻; n = 22), or wild type (Msh2(WT); n = 18) for the DNA mismatch repair gene Msh2. Control mice (45 Msh2⁻(/)⁻, 38 Msh2(+/)⁻, and 12 Msh2(WT)) received drinking water lacking azathioprine. The effect of azathioprine on tumorigenesis and survival of the mice was evaluated by Kaplan-Meier curves using log-rank and Gehan-Breslow-Wilcoxon tests. Mouse tumor samples were characterized by histology and immunophenotyping, and their MSI status was determined by polymerase chain reaction analysis of three noncoding microsatellite markers and by immunohistochemistry. Msh2 status of tumor samples was assessed by loss of heterozygosity analyses and sequencing after reverse transcription-polymerase chain reaction of the entire Msh2 coding sequence. All statistical tests were two-sided.
RESULTS: Most untreated Msh2(WT) and Msh2(+/)⁻ mice remained asymptomatic and alive at 250 days of age, whereas azathioprine-treated Msh2(WT) and Msh2(+/)⁻ mice developed lymphomas and died prematurely (median survival of 71 and 165 days of age, respectively). Azathioprine-treated Msh2(+/)⁻ mice developed diffuse lymphomas lacking Msh2 expression and displaying MSI due to somatic inactivation of the functional Msh2 allele by loss of heterozygosity or mutation. By contrast, azathioprine-treated Msh2(WT) mice displayed no obvious tumor phenotype, but histological examination showed microscopic splenic foci of neoplastic lymphoid cells that retained Msh2 expression and did not display MSI. Both untreated and azathioprine-treated Msh2⁻(/)⁻ mice had a reduced lifespan compared with untreated Msh2(WT) mice (median survival of 127 and 107 days of age, respectively) and developed lymphomas with MSI.
CONCLUSION: Azathioprine-induced carcinogenesis in mice depends on the number of functional copies of the Msh2 gene.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20923998     DOI: 10.1093/jnci/djq389

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  10 in total

1.  Azathioprine May Not be Associated With Development of Colorectal Tumors With Microsatellite Instability in Patients With Inflammatory Bowel Disease.

Authors:  Magali Svrcek; Laurent Beaugerie; Julien Kirchgesner; Sylvie Dumont; Martine Muleris; Sahra Bodo; Peggy Dartigues; Olivier Lascols; Philippe Seksik; Jacques Cosnes; Jean-François Fléjou; Alex Duval
Journal:  Am J Gastroenterol       Date:  2016-01       Impact factor: 10.864

Review 2.  Acute myeloid leukemia developing in patients with autoimmune diseases.

Authors:  Safaa M Ramadan; Tamer M Fouad; Valentina Summa; Syed Kh Hasan; Francesco Lo-Coco
Journal:  Haematologica       Date:  2011-12-16       Impact factor: 9.941

3.  Azathioprine does not reduce adenoma formation in a mouse model of sporadic intestinal tumorigenesis.

Authors:  Mattheus C B Wielenga; Jooske F van Lidth de Jeude; Sanne L Rosekrans; Alon D Levin; Monique Schukking; Geert R A M D'Haens; Jarom Heijmans; Marnix Jansen; Vanesa Muncan; Gijs R van den Brink
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 4.  Review of the literature and suggestions for the design of rodent survival studies for the identification of compounds that increase health and life span.

Authors:  Stephen Richard Spindler
Journal:  Age (Dordr)       Date:  2011-03-22

5.  Thiopurine methyltransferase predicts the extent of cytotoxicty and DNA damage in astroglial cells after thioguanine exposure.

Authors:  Amira Hosni-Ahmed; Joseph D Barnes; Jim Wan; Terreia S Jones
Journal:  PLoS One       Date:  2011-12-21       Impact factor: 3.240

6.  An essential role of high-molecular-weight kininogen in endotoxemia.

Authors:  Aizhen Yang; Zhanli Xie; Bo Wang; Robert W Colman; Jihong Dai; Yi Wu
Journal:  J Exp Med       Date:  2017-08-09       Impact factor: 14.307

7.  Azathioprine induction of tumors with microsatellite instability: risk evaluation using a mouse model.

Authors:  Sahra Bodo; Magali Svrcek; Isabelle Sourrouille; Peggy Cuillières-Dartigues; Tatiana Ledent; Sylvie Dumont; Laetitia Dinard; Philippe Lafitte; Camille Capel; Ada Collura; Olivier Buhard; Kristell Wanherdrick; Alexandra Chalastanis; Virginie Penard-Lacronique; Bettina Fabiani; Jean-François Fléjou; Nicole Brousse; Laurent Beaugerie; Alex Duval; Martine Muleris
Journal:  Oncotarget       Date:  2015-09-22

8.  The mutational profile and infiltration pattern of murine MLH1-/- tumors: concurrences, disparities and cell line establishment for functional analysis.

Authors:  Claudia Maletzki; Franziska Beyrich; Maja Hühns; Ernst Klar; Michael Linnebacher
Journal:  Oncotarget       Date:  2016-08-16

9.  Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells.

Authors:  Yulan Qing; Stanton L Gerson
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

10.  Muir-Torre syndrome: sebaceous carcinoma concurrent with colon cancer in a kidney transplant recipient; a case report.

Authors:  Masahiro Tomonari; Mariko Shimada; Yasuyuki Nakada; Izumi Yamamoto; Munenari Itoh; Yusuke Koike; Akimitsu Kobayashi; Jun Miki; Hiroki Yamada; Takahiro Kimura; Shinya Saito; Kokichi Sugano; Shigeki Sekine; Hiroyasu Yamamoto; Akihiko Asahina; Takashi Yokoo
Journal:  BMC Nephrol       Date:  2019-10-29       Impact factor: 2.388

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.